Origins and Future of Medical Imaging with Dr. David Sodickson Function Health TRANSCRIPT
Release Date: 02/12/2026
Driving Innovation in Cell Therapy Manufacturing with Ryan Clarke Syntax Bio TRANSCRIPT
Empowered Patient Podcast
Ryan Clarke, Co-Founder and CTO of Syntax Bio, is focused on solving manufacturing challenges in producing stem cell-derived therapies, specifically the process of stem cell differentiation. The Cellgorithm platform was designed to make differentiation an engineering problem by using a modified form of CRISPR to turn genes on and off in a specific, controlled sequence, reducing processing time from months to days and resulting in cost savings. One goal is to use AI and machine learning to build models capable of predicting optimal gene regulation sequences accelerating the discovery of...
info_outline
Driving Innovation in Cell Therapy Manufacturing with Ryan Clarke Syntax Bio
Empowered Patient Podcast
Ryan Clarke, Co-Founder and CTO of Syntax Bio, is focused on solving manufacturing challenges in producing stem cell-derived therapies, specifically the process of stem cell differentiation. The Cellgorithm platform was designed to make differentiation an engineering problem by using a modified form of CRISPR to turn genes on and off in a specific, controlled sequence, reducing processing time from months to days and resulting in cost savings. One goal is to use AI and machine learning to build models capable of predicting optimal gene regulation sequences accelerating the discovery of...
info_outline
Origins and Future of Medical Imaging with Dr. David Sodickson Function Health TRANSCRIPT
Empowered Patient Podcast
Dr. Daniel Sodickson is Chief Medical Scientist at Function Health and author of the new book, The Future of Seeing: How Imaging Is Changing Our World. Building on the drive to improve medical imaging, AI and neural networks are now reshaping image interpretation and how and what data are collected. This approach produces high-quality results with minimal additional data and is inspiring innovative scanning techniques and equipment design. The future of medical imaging is the everywhere scanner, enhancing a single-shot session with a large hospital machine with continuous health...
info_outline
Origins and Future of Medical Imaging with Dr. David Sodickson Function Health
Empowered Patient Podcast
Dr. Daniel Sodickson is Chief Medical Scientist at Function Health and author of the new book, The Future of Seeing: How Imaging Is Changing Our World. Building on the drive to improve medical imaging, AI and neural networks are now reshaping image interpretation and how and what data are collected. This approach produces high-quality results with minimal additional data and is inspiring innovative scanning techniques and equipment design. The future of medical imaging is the everywhere scanner, enhancing a single-shot session with a large hospital machine with continuous health...
info_outline
Stem Cell Therapy Aims to Rebuild Brain Circuits in Parkinson’s Patients with Dr. Howard Federoff Kenai Therapeutics TRANSCRIPT
Empowered Patient Podcast
Dr. Howard Federoff, Scientific Co-Founder, Chief Medical Officer, and Executive Vice President of Corporate Medicine and Science at Kenai Therapeutics, is developing a cell therapy for Parkinson's disease that involves transplanting IPSCs into the brain to replace lost dopamine neurons. The goal is not to cure the underlying cause of the disease, but to restore motor function and reverse the disease's progression. Initial clinical focus was on patients with moderate to moderate-severe idiopathic Parkinson's, showing efficacy and safety, leading to expanding the study to include...
info_outline
Stem Cell Therapy Aims to Rebuild Brain Circuits in Parkinson’s Patients with Dr. Howard Federoff Kenai Therapeutics
Empowered Patient Podcast
Dr. Howard Federoff, Scientific Co-Founder, Chief Medical Officer, and Executive Vice President of Corporate Medicine and Science at Kenai Therapeutics, is developing a cell therapy for Parkinson's disease that involves transplanting IPSCs into the brain to replace lost dopamine neurons. The goal is not to cure the underlying cause of the disease, but to restore motor function and reverse the disease's progression. Initial clinical focus was on patients with moderate to moderate-severe idiopathic Parkinson's, showing efficacy and safety, leading to expanding the study to include...
info_outline
Transforming MRI Data to Identify Biomarkers for Diagnosing and Treating Back Pain with Brent Ness Aclarion TRANSCRIPT
Empowered Patient Podcast
Brent Ness, CEO and President of Aclarion, highlights the challenges of diagnosing and treating chronic lower back pain, a leading driver of healthcare costs and opioid addiction. Traditional MRI and CT imaging do not reveal the biochemical source of pain within spinal discs, leading to misdiagnosis and unsuccessful treatment. The Aclarion technology uses MR spectroscopy to measure pain-causing biomarkers and, through a cloud-based, AI-powered SaaS model, analyzes the raw data and sends the physician a report within minutes. Brent explains, "The diagnosis and accurate treatment planning...
info_outline
Transforming MRI Data to Identify Biomarkers for Diagnosing and Treating Back Pain with Brent Ness Aclarion
Empowered Patient Podcast
Brent Ness, CEO and President of Aclarion, highlights the challenges of diagnosing and treating chronic lower back pain, a leading driver of healthcare costs and opioid addiction. Traditional MRI and CT imaging do not reveal the biochemical source of pain within spinal discs, leading to misdiagnosis and unsuccessful treatment. The Aclarion technology uses MR spectroscopy to measure pain-causing biomarkers and, through a cloud-based, AI-powered SaaS model, analyzes the raw data and sends the physician a report within minutes. Brent explains, "The diagnosis and accurate treatment planning...
info_outline
First Non-Steroidal MRA Drug Approved for Heart Failure with Dr. Alanna Morris-Simon Bayer TRANSCRIPT
Empowered Patient Podcast
Dr. Alanna Morris-Simon, Senior Medical Director for US Medical Affairs at Bayer, describes the symptoms and diagnostics used to classify heart failure and the key at-risk populations for this condition. The rapidly evolving landscape of heart failure treatments now includes the Bayer drug KERENDIA, a non-steroidal MRA approved to reduce cardiovascular death and heart failure in adults with an ejection fraction of 40% or more. This drug is part of an emerging trend to treat multiple related conditions simultaneously and could prevent the onset of heart failure and treat established...
info_outline
First Non-Steroidal MRA Drug Approved for Heart Failure with Dr. Alanna Morris-Simon Bayer
Empowered Patient Podcast
Dr. Alanna Morris-Simon, Senior Medical Director for US Medical Affairs at Bayer, describes the symptoms and diagnostics used to classify heart failure and the key at-risk populations for this condition. The rapidly evolving landscape of heart failure treatments now includes the Bayer drug KERENDIA, a non-steroidal MRA approved to reduce cardiovascular death and heart failure in adults with an ejection fraction of 40% or more. This drug is part of an emerging trend to treat multiple related conditions simultaneously and could prevent the onset of heart failure and treat established...
info_outlineDr. Daniel Sodickson is Chief Medical Scientist at Function Health and author of the new book, The Future of Seeing: How Imaging Is Changing Our World. Building on the drive to improve medical imaging, AI and neural networks are now reshaping image interpretation and how and what data are collected. This approach produces high-quality results with minimal additional data and is inspiring innovative scanning techniques and equipment design. The future of medical imaging is the everywhere scanner, enhancing a single-shot session with a large hospital machine with continuous health monitoring through wearables and devices integrated into everyday life.
Daniel explains, "One of the things that imaging can do is peel away all of the obscuring layers of skin or skull or whatever else there is, without having to make a single cut, and show us the inner workings, show us inner space, what's inside. I think that means being able to detect tumors early enough that they can be cured, to guide surgeries, to try to understand what normal anatomy is, and exactly when it turns abnormal. So I think the ability to see what was once invisible has become so much a part of medicine that it's almost hard to imagine it without it."
"There are many analogies between inner space and outer space, and between the tools we have built as humans over the millennia to inspect them. I guess what I'd say, though, is that somehow the inspection of inner space, that sort of medical imaging for understanding our health, is a little bit more intimate. It causes us to ask very personal questions like, " Am I okay? Are my kids okay? Am I normal? What is normal? I think when we look at other types of imaging, imaging the world around us, imaging the cosmos a great distance from us, there are also existential questions, but it's really more, where do I fit in the big picture? So I think in some ways medical imaging picks up where, say, astronomical imaging leaves off and leaves us wondering who we are and how we're built."
#DanielSodickson #FutureofSeeing #FunctionHealth #AIHealthcare #MedicalImaging #HealthTech #FunctionHealth #DigitalHealth #MRI #HealthcareInnovation #PatientEmpowerment #FutureOfMedicine #HealthcareAccessibility
The Future of Seeing: How Imaging Is Changing Our World
